The rise of copyright’s blockbuster initially fueled a surge for major pharmaceutical companies, but recent shifts present a uncertain scenario for investors. Lower-cost versions are eroding revenue, and persistent https://phoebekxqd827821.fare-blog.com/41588162/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment